Streetbeat News

Regulatory

BIIB

ESALY

The FDA has voted 6-0 in favor of Eisai and Biogen's Leqembi, a potential Alzheimer's treatment. Full approval would trigger broad coverage of Leqembi.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 7:52 pm

QBTS

D-Wave Quantum has received a Notice of Allowance for its US patent application 16/996,355 titled 'SYSTEMS AND METHODS FOR TUNING CAPACITANCE IN QUANTUM DEVICES'.

Portfolio Pulse from Charles Gross

June 09, 2023 | 7:41 pm

COIN

Coinbase shares are trading lower after Moody's cut its outlook to Negative amid SEC charges.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 7:10 pm

SNOA

Sonoma Pharmaceuticals announced its next-generation solution for pulse lavage irrigation in the European Union. The new product aims to improve surgical outcomes and reduce complications.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 7:01 pm

UNAM

Unico American Corporation (UNAM) announced it received a notice of delisting from the Nasdaq after its principal subsidiary, Crusader Insurance Company, was placed in conservation.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 6:57 pm

USDCUSD

The U.S. House Financial Services Committee has unveiled a bipartisan draft bill addressing stablecoin regulations, aiming to provide clarity on the digital asset ecosystem. The bill outlines the roles and responsibilities of federal payment stablecoin regulators and covers various aspects, including issuance, supervision, and enforcement. The draft also proposes amendments to the Investment Advisers Act of 1940, stating that payment stablecoins are not securities.

Portfolio Pulse from Murtuza Merchant

June 09, 2023 | 6:31 pm

COPHF

MNMD

Creso Pharma (OTC:COPHF) signed a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr. Hysek AG for an exclusive partnership to import and distribute licensed MDMA and psilocybin products into Australia. The partnership follows Australia's new legal framework for psychedelic-assisted therapies, and Creso Pharma will provide import infrastructure through its subsidiary Health House International (HHI).

Portfolio Pulse from Lara Goldstein

June 09, 2023 | 6:27 pm

UBER

The Cannabis Industry Council (CIC) calls for an urgent review of driving legislation in response to the legalization of medical cannabis, as current legislation is potentially discriminatory and outdated. The CIC recommends standardizing guidelines to focus on impairment, utilizing the Field Impairment Test (FIT), and improving communication and awareness among medical cannabis patients.

Portfolio Pulse from Joana Scopel

June 09, 2023 | 6:16 pm

BLUE

CRSP

VRTX

The FDA has accepted Vertex Pharmaceuticals and CRISPR Therapeutics' exa-cel application for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). Priority review has been granted for SCD, while standard review has been granted for TDT. Analysts maintain positive ratings on CRISPR Therapeutics.

Portfolio Pulse from Vandana Singh

June 09, 2023 | 6:08 pm

VOR

Vor Biopharma presented updated data from the VBP101 Phase 1/2a study of trem-cel in acute myeloid leukemia patients, showing early encouraging results. The FDA also cleared the company's IND application for VCAR33ALLO, a T-cell therapy derived from allogeneic healthy donors.

Portfolio Pulse from Vandana Singh

June 09, 2023 | 6:03 pm